search icon
      blog search icon

      Why The NMTR Stock Fell Afterhours? - Stocks Telegraph

      By ST Staff

      Published on

      July 9, 2021

      7:41 AM UTC

      Why The NMTR Stock Fell Afterhours? - Stocks Telegraph

      At last check in after-hours trading, shares of clinical-stage company focused on rare and unmet needs in gastroenterology  9 Meters Biopharma Inc. (NMTR) were down -3.23% at $1.20. Last session, 9 Meters closed at $1.24, up 20.39% or $0.21. During regular trading, the share price of NMTR fluctuated between $1.03 and $1.42.

      There were 43.89 million shares of NMTR stock exchanged, more than the daily volume of 5.11 million for the past 50 days and higher than the volume for the year to date. NMTR stock has fallen 101.36% in the past 12 months and has risen 12.73% in the last week. Over the past three months, NMTR shares have increased by 4.20%, and the stock has dropped by -9.49% during the last six months.

      NMTR stock rose during the regular session on news that it will participate in a biotech conference but has lost ground after hours.

      NMTR will participate in which event?

      9 Meters Biopharma is a gastroenterology company focused on rare and unmet needs. NMTR is developing vurolenatide, an orphan disease medicine, in a Phase 2 clinical trial for short bowel syndrome (SBS). Larazotide, another tight junction regulator, is also being evaluated by NMTR to improve symptoms of celiac disease.

      NMTR CEO John Temperato will participate in a virtual fireside chat at a health event, announced 9 Meters Biopharma.

      The NMTR CEO will take part in the William Blair Biotech Focus Conference on July 14-15, 2021. Investors are invited to join NMTR’s webcast live. John Temperato, Chief Executive Officer of 9 Meters Biopharma, will present at the William Blair Biotech Focus Conference on Thursday, July 15, 2021 at 12:00 to 2:45 p.m. Eastern Time.

      The presentation will be webcast live and may be accessed on the Investors page of the company’s website at https://wsw.com/webcast/blair59/nmtr/1964248, where a replay of the presentation will also be available for a 30-day period.

      Moreover, at the conclusion of the annual Russell US Index reconstitution, 9 Meters Biopharma was added to the Russell 3000 Index, a broad-market index, and the Russell 2000 Index, a small-cap index. As of the opening of the US equity markets on Monday June 28, 2021, these updated Indexes are in effect.

      The Russell indexes represent the 4,000 biggest US stocks based on their total market capitalization as of May 7, 2021. FTSE Russell determines membership for its Russell indexes primarily through objective rankings and criteria that are associated with market capitalization.

      What its addition to Russell means for NMTR?

      NMTR’s perseverance and accomplishments, including adding 9 Meters to the Russell Indexes, are indicative of its efforts to become a treatment leader in rare and unmet gastrointestinal disorders. By including 9 Meters Biopharma (NMTR) in the Russell Indexes, the company will raise its visibility when it is nearing several key milestones.

      More From Stocks telegraph